Table 3.
Univariate and multivariate analyses of factors impacting stent dysfunction in 195 patients who underwent successful endoscopic ultrasound-guided gastroenterostomy or enteral stenting.
| Variables | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|
| Stent Dysfunction Yes/No |
p Value | p Value | OR (95% CI) | |
| Age <65 >65 |
14/79 10/92 |
0.265 |
- |
|
| Gender Male Female |
14/79 10/92 |
0.265 |
- |
|
| Type of malignancy Pancreatic Other |
20/121 4/50 |
0.232 |
- |
|
| Stage of disease Resectable/locally advanced Metastatic |
14/86 10/85 |
0.460 |
- |
|
| Ascites Yes No |
2/32 22/139 |
0.263 |
- |
|
| Biliary obstruction Yes No |
18/106 6/65 |
0.261 |
- |
|
| Stenosis location * Type I Type II Type III |
9/60 5/75 10/36 |
0.037 |
0.009 |
3.49 (1.35–9.02) |
| PS-ECOG 0–1 2–4 |
9/79 15/92 |
0.422 |
- |
|
| Endoscopic treatment EUS-GE ES |
2/63 22/108 |
0.004 |
0.005 |
8.55 (1.88–38.82) |
EUS-GE: endoscopic ultrasound-guided gastroenterostomy; ES: enteral stenting; SD: standard deviation; PS-ECOG: Eastern Cooperative Oncology Group performance status. * According to the Mutignani classification [26].